Clinical and echocardiographic parameter | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR(95% CI) | P-value | HR(95% CI) | P-value | |
Age | 1.045 (1.021–1.073) | 0.031 | 1.160 (0.339–3.375) | 0.471 |
Sex, female | 0.728 (0.264–2.011) | 0.540 |  |  |
Systolic blood pressure | 1.021 (1.005–1.038) | 0.010 | 0.984 (0.959–1.089) | 0.223 |
Diabetes mellitus | 1.320 (0.781–2.170) | 0.312 |  |  |
SLEDAI-2000 score | 1.030 (1.011–1.050) | 0.008 | 1.019 (0.994–1.044) | 0.162 |
Positive anti-double-stranded DNA | 1.356 (0.813–2.261) | 0.244 |  |  |
Positive antiphospholipid antibodies | 1.396(0.765–2.548) | 0.277 |  |  |
Glucocorticoids | 0.956 (0.565–1.618) | 0.868 |  |  |
IVSd | 0.983 (0.799–1.208) | 0.868 |  |  |
LVEDd | 0.997 (0.943–1.055) | 0.926 |  |  |
EDV | 1.006 (0.991–1.021) | 0.462 |  |  |
LVEF | 0.962 (0.910–1.018) | 0.962 |  |  |
LVM | 1.001 (0.991–1.021) | 0.802 |  |  |
E/ e′ | 0.973 (0.784–1.207) | 0.801 |  |  |
sPAP | 1.064 (1.041–1.088) |  < 0.001 | 1.018 (0.848–1.431) | 0.056 |
Endocardial LS | 1.055 (1.031–1.156) |  < 0.001 | 1.014 (1.002–1.035) | 0.025 |
LS gradient | 1.076 (0.701–1.645) | 0.738 |  |  |
Endocardial CS | 2.508 (1.501–4.191) |  < 0.001 | 1.051 (1.027–1.077) |  < 0.001 |
CS gradient | 1.114 (0.811–1.529) | 0.505 |  |  |